{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:38:54Z","timestamp":1793407134413,"version":"4.5.0"},"reference-count":196,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Chongqing Science Foundation Project","award":["CSTB2022NSCQ-MSX0860"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0860"]}]},{"name":"Chongqing\u00a0Medical\u00a0Youth\u00a0Top-notch\u00a0Talent Project","award":["YXQN202401"],"award-info":[{"award-number":["YXQN202401"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2023-NHLHCRF-YS-01"],"award-info":[{"award-number":["2023-NHLHCRF-YS-01"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270768"],"award-info":[{"award-number":["82270768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06199-w","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:54:49Z","timestamp":1777359289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Abnormal lipid metabolism in senescent renal tubular cells in diabetic nephropathy"],"prefix":"10.1007","volume":"83","author":[{"given":"Jingfang","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3080-8506","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"6","key":"6199_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-025-04352-z","volume":"15","author":"S Dakshitha","year":"2025","unstructured":"Dakshitha S, Ghimouz R, Murugan R, Marunganathan V, Subramanian R, Roy A et al (2025) Triclosan promotes neurotoxicity in diabetic conditions: an in vivo molecular assessment using zebrafish model. 3 Biotech 15(6):169. https:\/\/doi.org\/10.1007\/s13205-025-04352-z","journal-title":"3 Biotech"},{"issue":"12","key":"6199_CR2","doi-asserted-by":"publisher","first-page":"10485","DOI":"10.1007\/s11033-023-08882-8","volume":"50","author":"K Velumani","year":"2023","unstructured":"Velumani K, Arasu A, Issac PK, Kishore Kumar MS, Guru A, Arockiaraj J (2023) Advancements of fish-derived peptides for mucormycosis: a novel strategy to treat diabetic compilation. Mol Biol Rep 50(12):10485\u201310507. https:\/\/doi.org\/10.1007\/s11033-023-08882-8","journal-title":"Mol Biol Rep"},{"issue":"1","key":"6199_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113206","volume":"143","author":"R Murugan","year":"2024","unstructured":"Murugan R, Ashok K, Ramya Ranjan Nayak SP, Deivasigamani P, Almutairi MH, Almutairi BO et al (2024) COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes. Int Immunopharmacol 143(1):113206. https:\/\/doi.org\/10.1016\/j.intimp.2024.113206","journal-title":"Int Immunopharmacol"},{"key":"6199_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jksus.2022.102450","volume":"35","author":"SVR Purabi Sarkar","year":"2023","unstructured":"Purabi Sarkar SVR, Velayutham M, Guru A, Pasupuleti M, Al EM, Olayan AF, Boushra AJ, Arockiaraj J (2023) A synthetic antioxidant molecule, GP13 derived from cysteine desulfurase of spirulina, Arthrospira platensis exhibited anti-diabetic activity on L6 rat skeletal muscle cells through GLUT-4 pathway. J King Saud Univ Sci 35:1\u20137. https:\/\/doi.org\/10.1016\/j.jksus.2022.102450","journal-title":"J King Saud Univ Sci"},{"issue":"1","key":"6199_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.procbio.2023.09.019","volume":"134","author":"PS Priya","year":"2023","unstructured":"Priya PS, Pavithra V, Vaishnavi S, Pachaiappan R, Kumar TTA, Rady A et al (2023) Understanding the mechanisms and implications of acacetin in mitigating diabetic osteoporosis: insights from a zebrafish model. Process Biochem 134(1):63\u201374. https:\/\/doi.org\/10.1016\/j.procbio.2023.09.019","journal-title":"Process Biochem"},{"key":"6199_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.procbio.2024.04.012","volume":"142","author":"SPRR Nayak","year":"2024","unstructured":"Nayak SPRR, Haridevamuthu B, Murugan R, Dhivya LS, Venkatesan S, Almutairi MH et al (2024) Furan-based chalcone protects \u03b2-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing Peroxisome Proliferator-Activated Receptor agonists (PPAR-\u03b3) signaling. Process Biochem 142:149\u2013161. https:\/\/doi.org\/10.1016\/j.procbio.2024.04.012","journal-title":"Process Biochem"},{"issue":"4","key":"6199_CR7","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/dom.16183","volume":"27","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lin T, Lu J, He W, Chen H, Wen T et al (2025) Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: a population-based study. Diabetes Obes Metab 27(4):1902\u20131919. https:\/\/doi.org\/10.1111\/dom.16183","journal-title":"Diabetes Obes Metab"},{"key":"6199_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101268","volume":"54","author":"T Chen","year":"2025","unstructured":"Chen T, Sun X, Tsuei S, Yang R, Yip W, Fu H (2025) Care for end-stage kidney disease in China: progress, challenges, and recommendations. Lancet Reg Health West Pac 54:101268. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101268","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"6199_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee LE, Doke T, Mukhi D, Susztak K (2024) The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int 106(1):24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025","journal-title":"Kidney Int"},{"key":"6199_CR10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018121251","author":"MH Docherty","year":"2019","unstructured":"Docherty MH, O\u2019Sullivan ED, Bonventre JV, Ferenbach DA (2019) Cellular senescence in the kidney. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2018121251","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"6199_CR11","doi-asserted-by":"publisher","first-page":"F273","DOI":"10.1152\/ajprenal.00689.2016","volume":"313","author":"J Chen","year":"2017","unstructured":"Chen J, Zhang WW, Chen KH, Lin LR, Dai HZ, Li KL et al (2017) Urinary DCR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy. Am J Physiol Renal Physiol 313(2):F273\u2013F281. https:\/\/doi.org\/10.1152\/ajprenal.00689.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"6199_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellsig.2013.10.002","volume":"26","author":"J Liu","year":"2014","unstructured":"Liu J, Huang K, Cai GY, Chen XM, Yang JR, Lin LR et al (2014) Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell Signal 26(1):110\u2013121. https:\/\/doi.org\/10.1016\/j.cellsig.2013.10.002","journal-title":"Cell Signal"},{"issue":"4","key":"6199_CR13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128","author":"N Herranz","year":"2018","unstructured":"Herranz N, Gil J (2018) Mechanisms and functions of cellular senescence. J Clin Invest 128(4):1238\u20131246. https:\/\/doi.org\/10.1172\/JCI95148","journal-title":"J Clin Invest"},{"issue":"4","key":"6199_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C et al (2019) Cellular senescence: defining a path forward. Cell 179(4):813\u2013827. https:\/\/doi.org\/10.1016\/j.cell.2019.10.005","journal-title":"Cell"},{"issue":"12","key":"6199_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang B, Han J, Elisseeff JH, Demaria M (2024) The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol 25(12):958\u2013978. https:\/\/doi.org\/10.1038\/s41580-024-00727-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"635","key":"6199_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz2597","volume":"13","author":"S Lovisa","year":"2020","unstructured":"Lovisa S, Fletcher Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A et al (2020) Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal 13(635):eaaz2597. https:\/\/doi.org\/10.1126\/scisignal.aaz2597","journal-title":"Sci Signal"},{"issue":"2","key":"6199_CR17","doi-asserted-by":"publisher","first-page":"C374","DOI":"10.1152\/ajpcell.00096.2010","volume":"299","author":"J Satriano","year":"2010","unstructured":"Satriano J, Mansoury H, Deng A, Sharma K, Vallon V, Blantz RC, Thomson SC (2010) Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes. Am J Physiol Cell Physiol 299(2):C374\u2013C380. https:\/\/doi.org\/10.1152\/ajpcell.00096.2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"6199_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.kint.2020.03.026","volume":"98","author":"C Jia","year":"2020","unstructured":"Jia C, Ke Hong C, Fei X, Huan Zi D, Jie Y, Li Ming W et al (2020) Decoy receptor 2 mediation of the senescent phenotype of tubular cells by interacting with peroxiredoxin 1 presents a novel mechanism of renal fibrosis in diabetic nephropathy. Kidney Int 98(3):645\u2013662. https:\/\/doi.org\/10.1016\/j.kint.2020.03.026","journal-title":"Kidney Int"},{"issue":"6","key":"6199_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04972-w","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Chen Kh, Wang Lm, Luo J, Zheng Qy, He Yn (2022) Decoy receptor 2 mediates the apoptosis-resistant phenotype of senescent renal tubular cells and accelerates renal fibrosis in diabetic nephropathy. Cell Death Dis 13(6):522. https:\/\/doi.org\/10.1038\/s41419-022-04972-w","journal-title":"Cell Death Dis"},{"key":"6199_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2024.116571","volume":"254","author":"P Rattananinsruang","year":"2025","unstructured":"Rattananinsruang P, Noonin C, Thongboonkerd V (2025) Comparative analysis of various senescence inducers in proximal renal tubular cells. J Pharm Biomed Anal 254:116571. https:\/\/doi.org\/10.1016\/j.jpba.2024.116571","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"6199_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/0886022X.2022.2072743","volume":"44","author":"X Liu","year":"2022","unstructured":"Liu X, Du H, Sun Y, Shao L (2022) Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention. Ren Fail 44(1):790\u2013805. https:\/\/doi.org\/10.1080\/0886022X.2022.2072743","journal-title":"Ren Fail"},{"issue":"4","key":"6199_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.kint.2024.12.020","volume":"107","author":"AD Thompson","year":"2025","unstructured":"Thompson AD, Victor Santiago Raj P, Scholpa NE, Schnellmann RG (2025) Repurposing mitochondria-targeted therapeutics for kidney diseases. Kidney Int 107(4):617\u2013627. https:\/\/doi.org\/10.1016\/j.kint.2024.12.020","journal-title":"Kidney Int"},{"issue":"1","key":"6199_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05300-w","volume":"22","author":"R Ji","year":"2024","unstructured":"Ji R, Wei L, Zan Y, Li X, Ma S, Ma L et al (2024) ABI3BP promotes renal aging through Klotho-mediated ferroptosis. J Transl Med 22(1):514. https:\/\/doi.org\/10.1186\/s12967-024-05300-w","journal-title":"J Transl Med"},{"issue":"1","key":"6199_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F et al (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21(1):37\u201346. https:\/\/doi.org\/10.1038\/nm.3762","journal-title":"Nat Med"},{"issue":"11","key":"6199_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00794","volume":"9","author":"L Console","year":"2020","unstructured":"Console L, Scalise M, Giangregorio N, Tonazzi A, Barile M, Indiveri C (2020) The link between the mitochondrial fatty acid oxidation derangement and kidney injury. Front Physiol 9(11):794. https:\/\/doi.org\/10.3389\/fphys.2020.00794","journal-title":"Front Physiol"},{"issue":"1","key":"6199_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05078-y","volume":"81","author":"Y Hou","year":"2024","unstructured":"Hou Y, Tan E, Shi H, Ren X, Wan X, Wu W et al (2024) Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol Life Sci 81(1):23. https:\/\/doi.org\/10.1007\/s00018-023-05078-y","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"6199_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111868","volume":"17","author":"T Iwai","year":"2016","unstructured":"Iwai T, Kume S, Chin Kanasaki M, Kuwagata S, Araki H, Takeda N et al (2016) Stearoyl-CoA desaturase-1 protects cells against lipotoxicity-mediated apoptosis in proximal tubular cells. Int J Mol Sci 17(11):1868. https:\/\/doi.org\/10.3390\/ijms17111868","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6199_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0611-8","volume":"15","author":"K Stadler","year":"2015","unstructured":"Stadler K, Goldberg IJ, Susztak K (2015) The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease. Curr Diab Rep 15(7):40. https:\/\/doi.org\/10.1007\/s11892-015-0611-8","journal-title":"Curr Diab Rep"},{"issue":"6","key":"6199_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf042","volume":"80","author":"Z Wang","year":"2025","unstructured":"Wang Z, Dai Y, Jin R, Mo D, Hu Q, Huang Y et al (2025) Ferroptosis activation contributes to kidney aging in mice by promoting tubular cell senescence. J Gerontol A Biol Sci Med Sci 80(6):glaf042. https:\/\/doi.org\/10.1093\/gerona\/glaf042","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"6199_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000018403.61042.56","author":"Y Kamijo","year":"2002","unstructured":"Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T et al (2002) Identification of functions of peroxisome proliferator-activated receptor \u03b1 in proximal tubules. J Am Soc Nephrol. https:\/\/doi.org\/10.1097\/01.ASN.0000018403.61042.56","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"6199_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ki.1986.147","volume":"30","author":"DM Freeman","year":"1986","unstructured":"Freeman DM, Chan L, Yahaya H, Holloway P, Ross BD (1986) Magnetic resonance spectroscopy for the determination of renal metabolic rate in vivo. Kidney Int 30(1):35\u201342. https:\/\/doi.org\/10.1038\/ki.1986.147","journal-title":"Kidney Int"},{"issue":"9","key":"6199_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41581-022-00592-x","volume":"18","author":"S van der Rijt","year":"2022","unstructured":"van der Rijt S, Leemans JC, Florquin S, Houtkooper RH, Tammaro A (2022) Immunometabolic rewiring of tubular epithelial cells in kidney disease. Nat Rev Nephrol 18(9):588\u2013603. https:\/\/doi.org\/10.1038\/s41581-022-00592-x","journal-title":"Nat Rev Nephrol"},{"key":"6199_CR33","unstructured":"Garrett RH, Grisham CM (2010) Biochemistry. 4th , International ed. Boston, Mass: Brooks\/Cole; Cengage Learning"},{"issue":"1","key":"6199_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","volume":"117","author":"G Milligan","year":"2017","unstructured":"Milligan G, Shimpukade B, Ulven T, Hudson BD (2017) Complex pharmacology of free fatty acid receptors. Chem Rev 117(1):67\u2013110. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00056","journal-title":"Chem Rev"},{"issue":"11","key":"6199_CR35","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1111\/dom.13449","volume":"20","author":"S Spiller","year":"2018","unstructured":"Spiller S, Bl\u00fcher M, Hoffmann R (2018) Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab 20(11):2661\u20132669. https:\/\/doi.org\/10.1111\/dom.13449","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"6199_CR36","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurjpc\/zwad073","volume":"30","author":"Y Pan","year":"2023","unstructured":"Pan Y, Wu TT, Mao XF, Hou XG, Yang Y, Deng CJ et al (2023) Decreased free fatty acid levels associated with adverse clinical outcomes in coronary artery disease patients with type 2 diabetes: findings from the PRACTICE study. Eur J Prev Cardiol 30(8):730\u2013739. https:\/\/doi.org\/10.1093\/eurjpc\/zwad073","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"6199_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01050","volume":"11","author":"PH Lin","year":"2020","unstructured":"Lin PH, Duann P (2020) Dyslipidemia in kidney disorders: perspectives on mitochondria homeostasis and therapeutic opportunities. Front Physiol 11(3):1050. https:\/\/doi.org\/10.3389\/fphys.2020.01050","journal-title":"Front Physiol"},{"issue":"15","key":"6199_CR38","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1073\/pnas.95.15.8625","volume":"95","author":"D Hirsch","year":"1998","unstructured":"Hirsch D, Stahl A, Lodish HF (1998) A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A 95(15):8625\u20138629. https:\/\/doi.org\/10.1073\/pnas.95.15.8625","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6390","key":"6199_CR39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M et al (2018) Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360(6390):758\u2013763. https:\/\/doi.org\/10.1126\/science.aar2131","journal-title":"Science"},{"key":"6199_CR40","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017030314","author":"S Khan","year":"2018","unstructured":"Khan S, Cabral PD, Schilling WP, Schmidt ZW, Uddin AN, Gingras A et al (2018) Kidney proximal tubule lipoapoptosis is regulated by fatty acid transporter-2 (FATP2). J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2017030314","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"6199_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136845","volume":"5","author":"S Khan","year":"2020","unstructured":"Khan S, Gaivin R, Abramovich C, Boylan M, Calles J, Schelling JR (2020) Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression. JCI Insight 5(15):136845. https:\/\/doi.org\/10.1172\/jci.insight.136845","journal-title":"JCI Insight"},{"issue":"5","key":"6199_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/ATVBAHA.118.310797","volume":"38","author":"A Briot","year":"2018","unstructured":"Briot A, Decaunes P, Volat F, Belles C, Coupaye M, Ledoux S, Bouloumi\u00e9 A (2018) Senescence alters PPAR\u03b3 (Peroxisome Proliferator-Activated Receptor Gamma)-dependent fatty acid handling in human adipose tissue microvascular endothelial cells and favors inflammation. Arterioscler Thromb Vasc Biol 38(5):1134\u20131146. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310797","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6199_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155991","volume":"134","author":"J Wang","year":"2024","unstructured":"Wang J, Wang L, Feng X, Xu Y, Zhou L, Wang C, Wang M (2024) Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2. Phytomedicine 134:155991. https:\/\/doi.org\/10.1016\/j.phymed.2024.155991","journal-title":"Phytomedicine"},{"issue":"21","key":"6199_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-nutr-062220-112240","volume":"43","author":"J Storch","year":"2023","unstructured":"Storch J, Corsico B (2023) The multifunctional family of mammalian fatty acid-binding proteins. Annu Rev Nutr 43(21):25\u201354. https:\/\/doi.org\/10.1146\/annurev-nutr-062220-112240","journal-title":"Annu Rev Nutr"},{"issue":"10","key":"6199_CR45","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1074\/jbc.RA118.006848","volume":"294","author":"R Patil","year":"2019","unstructured":"Patil R, Mohanty B, Liu B, Chandrashekaran IR, Headey SJ, Williams ML et al (2019) A ligand-induced structural change in fatty acid\u2013binding protein 1 is associated with potentiation of peroxisome proliferator\u2013activated receptor \u03b1 agonists. J Biol Chem 294(10):3720\u20133734. https:\/\/doi.org\/10.1074\/jbc.RA118.006848","journal-title":"J Biol Chem"},{"issue":"15","key":"6199_CR46","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/ijms.49078","volume":"17","author":"IT Tsai","year":"2020","unstructured":"Tsai IT, Wu CC, Hung WC, Lee TL, Hsuan CF, Wei CT et al (2020) FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci 17(15):2338\u20132345. https:\/\/doi.org\/10.7150\/ijms.49078","journal-title":"Int J Med Sci"},{"issue":"22","key":"6199_CR47","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.2174\/0109298673268265231228125431","volume":"31","author":"Y Huang","year":"2024","unstructured":"Huang Y, Cui X, Li Z, Yuan S, Han Y, Xu X et al (2024) High-expression of FABP4 in tubules is a risk factor for poor prognosis in DKD patients. Curr Med Chem 31(22):3436\u20133446. https:\/\/doi.org\/10.2174\/0109298673268265231228125431","journal-title":"Curr Med Chem"},{"key":"6199_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116899","volume":"236","author":"YW Wu","year":"2025","unstructured":"Wu YW, Chen JW, Lin LY, Huang JH, Chang CC, Chang TT (2025) FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease. Biochem Pharmacol 236:116899. https:\/\/doi.org\/10.1016\/j.bcp.2025.116899","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"6199_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00231876","volume":"133","author":"CM Harmon","year":"1993","unstructured":"Harmon CM, Abumrad NA (1993) Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and ammo-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133(1):43\u201349. https:\/\/doi.org\/10.1007\/BF00231876","journal-title":"J Membr Biol"},{"issue":"1","key":"6199_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1017\/S0954422420000128","volume":"34","author":"E Ulug","year":"2021","unstructured":"Ulug E, Nergiz Unal R (2021) Dietary fatty acids and CD36-mediated cholesterol homeostasis: potential mechanisms. Nutr Res Rev 34(1):64\u201377. https:\/\/doi.org\/10.1017\/S0954422420000128","journal-title":"Nutr Res Rev"},{"issue":"9","key":"6199_CR51","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/cne.25089","volume":"529","author":"MK Edler","year":"2021","unstructured":"Edler MK, Johnson CT, Ahmed HS, Richardson JR (2021) Age, sex, and regional differences in scavenger receptor CD36 in the mouse braPotential relevance to cerebral amyloid angiopathy and Alzheimer\u2019s disease. J Comp Neurol 529(9):2209\u20132226. https:\/\/doi.org\/10.1002\/cne.25089","journal-title":"J Comp Neurol"},{"issue":"3","key":"6199_CR52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/biof.1821","volume":"48","author":"JM Zingg","year":"2022","unstructured":"Zingg JM, Stamatiou C, Montalto G, Daunert S (2022) Modulation of CD36-mediated lipid accumulation and senescence by vitamin E analogs in monocytes and macrophages. BioFactors 48(3):665\u2013682. https:\/\/doi.org\/10.1002\/biof.1821","journal-title":"BioFactors"},{"issue":"8","key":"6199_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082083","volume":"10","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Ahmad SS, Lim JH, Ahmad K, Shaikh S, Lee YS et al (2021) Interaction of fibromodulin and myostatin to regulate skeletal muscle aging: an opposite regulation in muscle aging, diabetes, and intracellular lipid accumulation. Cells 10(8):2083. https:\/\/doi.org\/10.3390\/cells10082083","journal-title":"Cells"},{"issue":"7942","key":"6199_CR54","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41586-022-05535-x","volume":"613","author":"V Moiseeva","year":"2023","unstructured":"Moiseeva V, Cisneros A, Sica V, Deryagin O, Lai Y, Jung S et al (2023) Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature 613(7942):169\u2013178. https:\/\/doi.org\/10.1038\/s41586-022-05535-x","journal-title":"Nature"},{"issue":"1","key":"6199_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1414070","volume":"2017","author":"L Feng","year":"2017","unstructured":"Feng L, Gu C, Li Y, Huang J (2017) High glucose promotes CD36 expression by upregulating peroxisome proliferator-activated receptor \u03b3 levels to exacerbate lipid deposition in renal tubular cells. BioMed Res Int 2017(1):1414070. https:\/\/doi.org\/10.1155\/2017\/1414070","journal-title":"BioMed Res Int"},{"issue":"2","key":"6199_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020045","volume":"2","author":"K Susztak","year":"2005","unstructured":"Susztak K, Ciccone E, McCue P, Sharma K, B\u00f6ttinger EP (2005) Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2(2):e45. https:\/\/doi.org\/10.1371\/journal.pmed.0020045","journal-title":"PLoS Med"},{"issue":"4","key":"6199_CR57","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.kint.2016.01.009","volume":"89","author":"H Yokoi","year":"2016","unstructured":"Yokoi H, Yanagita M (2016) Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease. Kidney Int 89(4):740\u2013742. https:\/\/doi.org\/10.1016\/j.kint.2016.01.009","journal-title":"Kidney Int"},{"key":"6199_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179724","author":"M Terasaki","year":"2024","unstructured":"Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T et al (2024) Glucose-dependent insulinotropic polypeptide inhibits AGE-induced NADPH oxidase-derived oxidative stress generation and foam cell formation in macrophages partly via AMPK activation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25179724","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6199_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.23876\/j.krcp.2018.37.1.30","volume":"37","author":"JH Jung","year":"2018","unstructured":"Jung JH, Choi JE, Song JH, Ahn SH (2018) Human CD36 overexpression in renal tubules accelerates the progression of renal diseases in a mouse model of folic acid-induced acute kidney injury. Kidney Res Clin Pract 37(1):30\u201340. https:\/\/doi.org\/10.23876\/j.krcp.2018.37.1.30","journal-title":"Kidney Res Clin Pract"},{"issue":"22","key":"6199_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212408","volume":"22","author":"CC Huang","year":"2021","unstructured":"Huang CC, Chou CA, Chen WY, Yang JL, Lee WC, Chen JB et al (2021) Empagliflozin ameliorates free fatty acid induced-lipotoxicity in renal proximal tubular cells via the PPAR\u03b3\/CD36 pathway in obese mice. Int J Mol Sci 22(22):12408. https:\/\/doi.org\/10.3390\/ijms222212408","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6199_CR61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/ars.2018.7634","volume":"31","author":"X Li","year":"2019","unstructured":"Li X, Zhang T, Geng J, Wu Z, Xu L, Liu J et al (2019) Advanced oxidation protein products promote lipotoxicity and tubulointerstitial fibrosis via CD36\/\u03b2-catenin pathway in diabetic nephropathy. Antioxid Redox Signal 31(7):521\u2013538. https:\/\/doi.org\/10.1089\/ars.2018.7634","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"6199_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03813-6","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wang Q, Han B, Chen Y, Qiao X, Wang L (2021) CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis 12(6):523. https:\/\/doi.org\/10.1038\/s41419-021-03813-6","journal-title":"Cell Death Dis"},{"issue":"5","key":"6199_CR63","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori Y, Ajay AK, Chang JH, Mou S, Zhao H, Kishi S et al (2021) KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab 33(5):1042\u20131061. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.004","journal-title":"Cell Metab"},{"issue":"3","key":"6199_CR64","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2024-0123en","volume":"47","author":"LE Oliveira","year":"2025","unstructured":"Oliveira LE, Paniz C, Moresco RN, Carvalho JAM (2025) KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance. J Bras Nefrol 47(3):e20240123. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2024-0123en","journal-title":"J Bras Nefrol"},{"issue":"29","key":"6199_CR65","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.2147\/IJGM.S361468","volume":"15","author":"S Peng","year":"2022","unstructured":"Peng S, Liu N, Wei K, Li G, Zou Z, Liu T et al (2022) The predicted value of kidney injury molecule-1 (KIM-1) in healthy people. Int J Gen Med 15(29):4495\u20134503. https:\/\/doi.org\/10.2147\/IJGM.S361468","journal-title":"Int J Gen Med"},{"issue":"10","key":"6199_CR66","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1507\/endocrj.EJ13-0079","volume":"60","author":"K Iizuka","year":"2013","unstructured":"Iizuka K, Wu W, Horikawa Y, Saito M, Takeda J (2013) Feedback looping between ChREBP and PPAR\u03b1 in the regulation of lipid metabolism in brown adipose tissues. Endocr J 60(10):1145\u20131153. https:\/\/doi.org\/10.1507\/endocrj.EJ13-0079","journal-title":"Endocr J"},{"issue":"Suppl 1","key":"6199_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000838056.28118.97","volume":"40","author":"A Leibowitz","year":"2022","unstructured":"Leibowitz A, Bier A, Shpira E, Khashab R, Sharabi Y, Grossman E (2022) High fructose diet increases renal chrebp-beta expression and leads to intra-renal fat accumulation in a metabolic-like syndrome rat model. J Hypertens 40(Suppl 1):e250. https:\/\/doi.org\/10.1097\/01.hjh.0000838056.28118.97","journal-title":"J Hypertens"},{"issue":"1","key":"6199_CR68","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yexcr.2015.06.006","volume":"336","author":"H Wang","year":"2015","unstructured":"Wang H, Zhu L, Hao J, Duan H, Liu S, Zhao S et al (2015) Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice. Exp Cell Res 336(1):76\u201384. https:\/\/doi.org\/10.1016\/j.yexcr.2015.06.006","journal-title":"Exp Cell Res"},{"issue":"2","key":"6199_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2292753","volume":"45","author":"H Niu","year":"2023","unstructured":"Niu H, Ren X, Tan E, Wan X, Wang Y, Shi H et al (2023) CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function. Ren Fail 45(2):2292753. https:\/\/doi.org\/10.1080\/0886022X.2023.2292753","journal-title":"Ren Fail"},{"issue":"11","key":"6199_CR70","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.yexcr.2011.02.003","volume":"317","author":"J Hao","year":"2011","unstructured":"Hao J, Zhu L, Zhao S, Liu S, Liu Q, Duan H (2011) PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1\/FASN\/ACC pathway in renal proximal tubular cells. Exp Cell Res 317(11):1629\u20131639. https:\/\/doi.org\/10.1016\/j.yexcr.2011.02.003","journal-title":"Exp Cell Res"},{"issue":"10","key":"6199_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12100940","volume":"12","author":"P Kayampilly","year":"2022","unstructured":"Kayampilly P, Roeser N, Rajendiran TM, Pennathur S, Afshinnia F (2022) Acetyl Co-A carboxylase inhibition halts hyperglycemia induced upregulation of de novo lipogenesis in podocytes and proximal tubular cells. Metabolites 12(10):940. https:\/\/doi.org\/10.3390\/metabo12100940","journal-title":"Metabolites"},{"key":"6199_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104778","volume":"156","author":"K Su","year":"2020","unstructured":"Su K, Yi B, Yao Bq, Xia T, Yang Yf, Zhang Zh, Chen C (2020) Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis. Pharmacol Res 156:104778. https:\/\/doi.org\/10.1016\/j.phrs.2020.104778","journal-title":"Pharmacol Res"},{"key":"6199_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176905","volume":"983","author":"B Yi","year":"2024","unstructured":"Yi B, Su K, Cai Y, Chen X, Bao Y, Wen Z (2024) Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-oxoproline. Eur J Pharmacol 983:176905. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176905","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"6199_CR74","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000525385","volume":"47","author":"W Gu","year":"2022","unstructured":"Gu W, Yang L, Wang X, Geng J, Li X, Zheng K et al (2022) Pterostilbene, a resveratrol derivative, improves ectopic lipid deposition in the kidneys of mice induced by a high-fat diet. Kidney Blood Press Res 47(8):514\u2013522. https:\/\/doi.org\/10.1159\/000525385","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"6199_CR75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172963","volume":"134","author":"D Mukhi","year":"2024","unstructured":"Mukhi D, Li L, Liu H, Doke T, Kolligundla LP, Ha E et al (2024) ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. J Clin Invest 134(4):e172963. https:\/\/doi.org\/10.1172\/JCI172963","journal-title":"J Clin Invest"},{"issue":"10","key":"6199_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23854","volume":"38","author":"G Pissas","year":"2024","unstructured":"Pissas G, Tziastoudi M, Divani M, Poulianiti C, Konsta MAP, Lykotsetas E et al (2024) Malate dehydrogenase-2 inhibition shields renal tubular epithelial cells from anoxia-reoxygenation injury by reducing reactive oxygen species. J Biochem Mol Toxicol 38(10):e23854. https:\/\/doi.org\/10.1002\/jbt.23854","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"6199_CR77","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13(4):227\u2013232. https:\/\/doi.org\/10.1038\/nrc3483","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"6199_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0127-z","volume":"9","author":"K Chen","year":"2018","unstructured":"Chen K, Dai H, Yuan J, Chen J, Lin L, Zhang W et al (2018) Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis 9(2):105. https:\/\/doi.org\/10.1038\/s41419-017-0127-z","journal-title":"Cell Death Dis"},{"key":"6199_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112609","volume":"197","author":"D Xu","year":"2024","unstructured":"Xu D, Moru P, Liao K, Song W, Yang P, Zang D et al (2024) High glucose-induced senescence contributes to tubular epithelial cell damage in diabetic nephropathy. Exp Gerontol 197:112609. https:\/\/doi.org\/10.1016\/j.exger.2024.112609","journal-title":"Exp Gerontol"},{"issue":"2","key":"6199_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.semnephrol.2018.01.003","volume":"38","author":"SY Li","year":"2018","unstructured":"Li SY, Susztak K (2018) The role of peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 (PGC-1\u03b1) in kidney disease. Semin Nephrol 38(2):121\u2013126. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.01.003","journal-title":"Semin Nephrol"},{"key":"6199_CR81","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013020126","author":"K Sharma","year":"2013","unstructured":"Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R et al (2013) Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2013020126","journal-title":"J Am Soc Nephrol"},{"key":"6199_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119579","volume":"345","author":"XM Shan","year":"2025","unstructured":"Shan XM, Lu C, Chen CW, Wang CT, Liu TT, An T et al (2025) Tangshenning formula alleviates tubular injury in diabetic kidney disease via the Sestrin2\/AMPK\/PGC-1\u03b1 axis: restoration of mitochondrial function and inhibition of ferroptosis. J Ethnopharmacol 345:119579. https:\/\/doi.org\/10.1016\/j.jep.2025.119579","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"6199_CR83","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41418-024-01365-8","volume":"31","author":"JX Zhang","year":"2024","unstructured":"Zhang JX, Chen PP, Li XQ, Li L, Wu QY, Wang GH et al (2024) Deficiency of thiosulfate sulfurtransferase mediates the dysfunction of renal tubular mitochondrial fatty acid oxidation in diabetic kidney disease. Cell Death Differ 31(12):1636\u20131649. https:\/\/doi.org\/10.1038\/s41418-024-01365-8","journal-title":"Cell Death Differ"},{"issue":"8","key":"6199_CR84","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/bph.12503","volume":"171","author":"GC Higgins","year":"2014","unstructured":"Higgins GC, Coughlan MT (2014) Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol 171(8):1917\u20131942. https:\/\/doi.org\/10.1111\/bph.12503","journal-title":"Br J Pharmacol"},{"key":"6199_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114252","volume":"159","author":"Q Hu","year":"2023","unstructured":"Hu Q, Chen Y, Deng X, Li Y, Ma X, Zeng J, Zhao Y (2023) Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation. Biomed Pharmacother 159:114252. https:\/\/doi.org\/10.1016\/j.biopha.2023.114252","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"6199_CR86","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403361R","volume":"39","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Shen M, Zhang B, Li X, Cheng H, Feng D et al (2025) A novel role of adipokine \u201cintelectin-1\u201d: ameliorating renal fibrosis through inhibition of renal tubular epithelial cell senescence. FASEB J 39(10):e70653. https:\/\/doi.org\/10.1096\/fj.202403361R","journal-title":"FASEB J"},{"issue":"1","key":"6199_CR87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5115\/acb.2015.48.1.54","volume":"48","author":"Y Kwon","year":"2015","unstructured":"Kwon Y, Kim J, Lee CY, Kim H (2015) Expression of SIRT1 and SIRT3 varies according to age in mice. ACB 48(1):54\u201361. https:\/\/doi.org\/10.5115\/acb.2015.48.1.54","journal-title":"ACB"},{"issue":"13","key":"6199_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136936","volume":"25","author":"F Juszczak","year":"2024","unstructured":"Juszczak F, Arnould T, Decl\u00e8ves AE (2024) The role of mitochondrial sirtuins (SIRT3, SIRT4 and SIRT5) in renal cell metabolism: implication for kidney diseases. Int J Mol Sci 25(13):6936. https:\/\/doi.org\/10.3390\/ijms25136936","journal-title":"Int J Mol Sci"},{"key":"6199_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101195","volume":"49","author":"S Amjad","year":"2021","unstructured":"Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K et al (2021) Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab 49:101195. https:\/\/doi.org\/10.1016\/j.molmet.2021.101195","journal-title":"Mol Metab"},{"key":"6199_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104975","author":"K Myakala","year":"2023","unstructured":"Myakala K, Wang XX, Shults NV, Krawczyk E, Jones BA, Yang X et al (2023) NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2023.104975","journal-title":"J Biol Chem"},{"issue":"5","key":"6199_CR91","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1128\/MCB.00586-15","volume":"36","author":"NR Sundaresan","year":"2015","unstructured":"Sundaresan NR, Bindu S, Pillai VB, Samant S, Pan Y, Huang JY et al (2015) Sirt3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3\u03b2. Mol Cell Biol 36(5):678\u2013692. https:\/\/doi.org\/10.1128\/MCB.00586-15","journal-title":"Mol Cell Biol"},{"issue":"8","key":"6199_CR92","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A et al (2019) ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest 129(8):3387\u20133400. https:\/\/doi.org\/10.1172\/JCI125316","journal-title":"J Clin Invest"},{"issue":"5","key":"6199_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2544-7","volume":"11","author":"T Cai","year":"2020","unstructured":"Cai T, Ke Q, Fang Y, Wen P, Chen H, Yuan Q et al (2020) Sodium\u2013glucose cotransporter 2 inhibition suppresses HIF-1\u03b1-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice. Cell Death Dis 11(5):390. https:\/\/doi.org\/10.1038\/s41419-020-2544-7","journal-title":"Cell Death Dis"},{"issue":"6","key":"6199_CR94","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.12182\/20231160107","volume":"54","author":"YI Xianglin","year":"2023","unstructured":"Xianglin YI, Yani HE, Kehong C (2023) Research progress in stress-induced senescence of renal tubular cells in diabetic nephropathy. J Sichuan Univ Med Sci Ed 54(6):1085\u20131090. https:\/\/doi.org\/10.12182\/20231160107","journal-title":"J Sichuan Univ Med Sci Ed"},{"issue":"3","key":"6199_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18075","volume":"28","author":"Q Wu","year":"2024","unstructured":"Wu Q, Chen Q, Xu D, Wang X, Ye H, Li X et al (2024) C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through \u03b2-catenin-inhibited fatty acid oxidation. J Cell Mol Med 28(3):e18075. https:\/\/doi.org\/10.1111\/jcmm.18075","journal-title":"J Cell Mol Med"},{"issue":"3","key":"6199_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179362","volume":"10","author":"S Ito","year":"2025","unstructured":"Ito S, Taguchi K, Kodama G, Kubo S, Moriyama T, Yamashita Y et al (2025) Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease. JCI Insight 10(3):e179362. https:\/\/doi.org\/10.1172\/jci.insight.179362","journal-title":"JCI Insight"},{"issue":"18","key":"6199_CR97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/DMSO.S289712","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Ni L, Zhang L, Zha D, Hu C, Zhang L et al (2021) Empagliflozin regulates the AdipoR1\/p-AMPK\/p-ACC pathway to alleviate lipid deposition in diabetic nephropathy. Diabetes Metab Syndr Obes 14(18):227\u2013240. https:\/\/doi.org\/10.2147\/DMSO.S289712","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"6199_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14501","volume":"24","author":"L Sun","year":"2025","unstructured":"Sun L, Xu L, Duan T, Xi Y, Deng Z, Luo S et al (2025) CAV1 exacerbates renal tubular epithelial cell senescence by suppressing CaMKK2\/AMPK-mediated autophagy. Aging Cell 24(5):e14501. https:\/\/doi.org\/10.1111\/acel.14501","journal-title":"Aging Cell"},{"key":"6199_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154334","volume":"111","author":"X Liu","year":"2020","unstructured":"Liu X, Xu C, Xu L, Li X, Sun H, Xue M et al (2020) Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway. Metabolism 111:154334. https:\/\/doi.org\/10.1016\/j.metabol.2020.154334","journal-title":"Metabolism"},{"issue":"10","key":"6199_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04184-8","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Tang S, Liu Y, Li A, Zhan M, Yang M et al (2021) AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis 12(10):925. https:\/\/doi.org\/10.1038\/s41419-021-04184-8","journal-title":"Cell Death Dis"},{"key":"6199_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156776","volume":"145","author":"S Zhang","year":"2025","unstructured":"Zhang S, Wen Z, Chen Y, Yang Y, Song C, Wang J et al (2025) Keluoxin reduces renal lipid deposition in diabetic nephropathy via AMPK\/NF-\u03baB-mediated mtabolic regulation. Phytomedicine 145:156776. https:\/\/doi.org\/10.1016\/j.phymed.2025.156776","journal-title":"Phytomedicine"},{"key":"6199_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2024.08.002","volume":"106\u2013107","author":"V Penugurti","year":"2024","unstructured":"Penugurti V, Manne RK, Bai L, Kant R, Lin HK (2024) AMPK: the energy sensor at the crossroads of aging and cancer. Semin Cancer Biol 106\u2013107:15\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2024.08.002","journal-title":"Semin Cancer Biol"},{"key":"6199_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119398","volume":"342","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Zhan H, Yuan H, Wang N, Lan Y, Qu W et al (2025) Boeravinone C ameliorates lipid accumulation and inflammation in diabetic kidney disease by activating PPAR\u03b1 signaling. J Ethnopharmacol 342:119398. https:\/\/doi.org\/10.1016\/j.jep.2025.119398","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"6199_CR104","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung KW, Lee EK, Lee MK, Oh GT, Yu BP, Chung HY (2018) Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol 29(4):1223\u20131237. https:\/\/doi.org\/10.1681\/ASN.2017070802","journal-title":"J Am Soc Nephrol"},{"key":"6199_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114562","volume":"154","author":"Y Wang","year":"2025","unstructured":"Wang Y, Feng X, Li Y, Niu S, Li J, Shi H et al (2025) Targeting inflammation and necroptosis in diabetic kidney disease: a novel approach via PPAR\u03b1 modulation. Int Immunopharmacol 154:114562. https:\/\/doi.org\/10.1016\/j.intimp.2025.114562","journal-title":"Int Immunopharmacol"},{"key":"6199_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155450","volume":"126","author":"M Wang","year":"2024","unstructured":"Wang M, Wang L, Zhou L, Xu Y, Wang C (2024) Shen-Shuai-II-recipe inhibits tubular inflammation by PPAR\u03b1-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys. Phytomedicine 126:155450. https:\/\/doi.org\/10.1016\/j.phymed.2024.155450","journal-title":"Phytomedicine"},{"issue":"2","key":"6199_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148141","volume":"11","author":"SE Park","year":"2016","unstructured":"Park SE, Park CY, Choi JM, Chang E, Rhee EJ, Lee WY et al (2016) Depot-specific changes in fat metabolism with aging in a type 2 diabetic animal model. PLoS One 11(2):e0148141. https:\/\/doi.org\/10.1371\/journal.pone.0148141","journal-title":"PLoS One"},{"key":"6199_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.931331","volume":"3","author":"GJ Prud\u2019homme","year":"2022","unstructured":"Prud\u2019homme GJ, Kurt M, Wang Q (2022) Pathobiology of the Klotho antiaging protein and therapeutic considerations. Frontiers in Aging 3:931331. https:\/\/doi.org\/10.3389\/fragi.2022.931331","journal-title":"Frontiers in Aging"},{"key":"6199_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106841","volume":"194","author":"H Gao","year":"2023","unstructured":"Gao H, Nepovimova E, Heger Z, Valko M, Wu Q, Kuca K, Adam V (2023) Role of hypoxia in cellular senescence. Pharmacol Res 194:106841. https:\/\/doi.org\/10.1016\/j.phrs.2023.106841","journal-title":"Pharmacol Res"},{"issue":"6","key":"6199_CR110","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","volume":"9","author":"J Krishnan","year":"2009","unstructured":"Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit C et al (2009) Activation of a HIF1\u03b1-PPAR\u03b3 axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 9(6):512\u2013524. https:\/\/doi.org\/10.1016\/j.cmet.2009.05.005","journal-title":"Cell Metab"},{"issue":"12","key":"6199_CR111","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92(12):5510\u20135514. https:\/\/doi.org\/10.1073\/pnas.92.12.5510","journal-title":"Proc Natl Acad Sci USA"},{"key":"6199_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101169","volume":"47","author":"IL Lemmer","year":"2021","unstructured":"Lemmer IL, Willemsen N, Hilal N, Bartelt A (2021) A guide to understanding endoplasmic reticulum stress in metabolic disorders. Mol Metab 47:101169. https:\/\/doi.org\/10.1016\/j.molmet.2021.101169","journal-title":"Mol Metab"},{"issue":"12","key":"6199_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05444-x","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo J, Yang N, Huang Y, Hu T, Rao C (2022) Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis 13(12):1051. https:\/\/doi.org\/10.1038\/s41419-022-05444-x","journal-title":"Cell Death Dis"},{"issue":"1","key":"6199_CR114","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/glia.24082","volume":"70","author":"SG Sims","year":"2022","unstructured":"Sims SG, Cisney RN, Lipscomb MM, Meares GP (2022) The role of endoplasmic reticulum stress in astrocytes. Glia 70(1):5\u201319. https:\/\/doi.org\/10.1002\/glia.24082","journal-title":"Glia"},{"key":"6199_CR115","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020222","author":"XX Wang","year":"2018","unstructured":"Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ et al (2018) FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2017020222","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"6199_CR116","doi-asserted-by":"publisher","first-page":"C621","DOI":"10.1152\/ajpcell.00096.2014","volume":"308","author":"J Liu","year":"2015","unstructured":"Liu J, Yang JR, Chen XM, Cai GY, Lin LR, He YN (2015) Impact of ER stress-regulated ATF4\/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. Am J Physiol Cell Physiol 308(8):C621\u2013C630. https:\/\/doi.org\/10.1152\/ajpcell.00096.2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"6199_CR117","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13052","volume":"54","author":"L Chen","year":"2021","unstructured":"Chen L, Mei G, Jiang C, Cheng X, Li D, Zhao Y et al (2021) Carbon monoxide alleviates senescence in diabetic nephropathy by improving autophagy. Cell Prolif 54(6):e13052. https:\/\/doi.org\/10.1111\/cpr.13052","journal-title":"Cell Prolif"},{"issue":"5","key":"6199_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2594-x","volume":"11","author":"X Jiang","year":"2020","unstructured":"Jiang X, Xiang X, Chen X, He J, Liu T, Gan H, Du X (2020) Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy. Cell Death Dis 11(5):385. https:\/\/doi.org\/10.1038\/s41419-020-2594-x","journal-title":"Cell Death Dis"},{"issue":"1","key":"6199_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00993-z","volume":"19","author":"J Shi","year":"2024","unstructured":"Shi J, Wang Y, Liang T, Wang X, Xie J, Huang R et al (2024) DMDD, isolated from Averrhoa carambola L., ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-autophagy crosstalk. Chin Med 19(1):125. https:\/\/doi.org\/10.1186\/s13020-024-00993-z","journal-title":"Chin Med"},{"issue":"1","key":"6199_CR120","first-page":"83","volume":"12","author":"P Kimmelstiel","year":"1936","unstructured":"Kimmelstiel P, Wilson C (1936) Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 12(1):83-98.87","journal-title":"Am J Pathol"},{"key":"6199_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751529","volume":"8","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang S, Guo J (2021) Lipotoxic proximal tubular injury: a primary event in diabetic kidney disease. Front Med 8:751529. https:\/\/doi.org\/10.3389\/fmed.2021.751529","journal-title":"Front Med"},{"issue":"4","key":"6199_CR122","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.kint.2018.10.038","volume":"95","author":"X Chen","year":"2019","unstructured":"Chen X, Han Y, Gao P, Yang M, Xiao L, Xiong X et al (2019) Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney Int 95(4):880\u2013895. https:\/\/doi.org\/10.1016\/j.kint.2018.10.038","journal-title":"Kidney Int"},{"issue":"1","key":"6199_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-025-01971-1","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Chen H, Tian C, Fu L, Nie L, Wang R, Zeng X (2025) Renal ectopic fat deposition and hemodynamics in type 2 diabetes mellitus assessment with magnetic resonance imaging. Insights Imaging 16(1):93. https:\/\/doi.org\/10.1186\/s13244-025-01971-1","journal-title":"Insights Imaging"},{"issue":"3","key":"6199_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70027","volume":"4","author":"F Zhang","year":"2025","unstructured":"Zhang F, Li R, Liu Y, Liang J, Gong Y, Xiao C et al (2025) Integrative cross-tissue analysis unveils complement-immunoglobulin augmentation and dysbiosis-related fatty acid metabolic remodeling during mammalian aging. iMeta 4(3):e70027. https:\/\/doi.org\/10.1002\/imt2.70027","journal-title":"iMeta"},{"issue":"6","key":"6199_CR125","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.7150\/ijbs.93598","volume":"20","author":"J Lu","year":"2024","unstructured":"Lu J, Sun W, Liu B, Zhang J, Wang R, Goltzman D, Miao D (2024) Chk2 modulates Bmi1-deficiency-induced renal aging and fibrosis via oxidative stress, DNA damage, and p53\/TGFbeta1-induced epithelial-mesenchymal transition. Int J Biol Sci 20(6):2008\u20132026. https:\/\/doi.org\/10.7150\/ijbs.93598","journal-title":"Int J Biol Sci"},{"issue":"10","key":"6199_CR126","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41401-024-01298-5","volume":"45","author":"YB Xiong","year":"2024","unstructured":"Xiong YB, Huang WY, Ling X, Zhou S, Wang XX, Li XL, Zhou LL (2024) Mitochondrial calcium uniporter promotes kidney aging in mice through inducing mitochondrial calcium-mediated renal tubular cell senescence. Acta Pharmacol Sin 45(10):2149\u20132162. https:\/\/doi.org\/10.1038\/s41401-024-01298-5","journal-title":"Acta Pharmacol Sin"},{"key":"6199_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609580","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang M, Han Y, Luo S, Xiong X, Zhu X, Zhao H et al (2021) MAMs protect against ectopic fat deposition and lipid-related kidney damage in DN patients. Front Endocrinol 12:609580. https:\/\/doi.org\/10.3389\/fendo.2021.609580","journal-title":"Front Endocrinol"},{"issue":"2","key":"6199_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin Hl, Huang Zj, Lin Zt, Mao N et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"6199_CR129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","volume":"16","author":"Y Han","year":"2018","unstructured":"Han Y, Xu X, Tang C, Gao P, Chen X, Xiong X et al (2018) Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol 16:32\u201346. https:\/\/doi.org\/10.1016\/j.redox.2018.02.013","journal-title":"Redox Biol"},{"issue":"2","key":"6199_CR130","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-024-01381-8","volume":"32","author":"K Lai","year":"2025","unstructured":"Lai K, Chen Z, Lin S, Ye K, Yuan Y, Li G et al (2025) The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction. Cell Death Differ 32(2):242\u2013255. https:\/\/doi.org\/10.1038\/s41418-024-01381-8","journal-title":"Cell Death Differ"},{"key":"6199_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202505168","author":"Z Liu","year":"2025","unstructured":"Liu Z, Huang T, Hong Y, Yang Y, Chen W, Zeng Q et al (2025) Adaptive antioxidant nanomedicines inhibit ferroptosis in renal tubular epithelial cells to alleviate diabetic kidney disease. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202505168","journal-title":"Adv Sci"},{"key":"6199_CR132","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2022.12.088","volume":"195","author":"QY Lu","year":"2023","unstructured":"Lu QY, Yang LJ, Xiao JJ, Liu Q, Ni LH, Hu JW et al (2023) Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK\/NRF2 pathway. Free Radic Biol Med 195:89\u2013102. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.12.088","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"6199_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409781","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Zhou S, Wu W, lin Y, Wang T, Sun H et al (2025) GLP-1 receptor agonists alleviate diabetic kidney injury via \u03b2-klotho-mediated ferroptosis inhibition. Adv Sci 12(4):2409781. https:\/\/doi.org\/10.1002\/advs.202409781","journal-title":"Adv Sci"},{"issue":"25","key":"6199_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416441","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Liu D, Lei L, Liu T, Pan S, Wang H et al (2025) CNPY2 aggravates renal tubular cell ferroptosis in diabetic nephropathy by regulating PERK\/ATF4\/CHAC1 pathway and MAM integrity. Adv Sci (Weinh) 12(25):e2416441. https:\/\/doi.org\/10.1002\/advs.202416441","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"6199_CR135","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3803\/EnM.2022.1604","volume":"38","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lei Y, Huang M, Cheng L, Guan H et al (2023) Inhibition of fatty acid \u03b2-oxidation by fatty acid binding protein 4 induces ferroptosis in HK2 cells under high glucose conditions. enm 38(2):226\u2013244. https:\/\/doi.org\/10.3803\/EnM.2022.1604","journal-title":"enm"},{"key":"6199_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.112139","volume":"582","author":"T Gan","year":"2024","unstructured":"Gan T, Wang Q, Song Y, Shao M, Zhao Y, Guo F et al (2024) Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease. Mol Cell Endocrinol 582:112139. https:\/\/doi.org\/10.1016\/j.mce.2023.112139","journal-title":"Mol Cell Endocrinol"},{"issue":"7242","key":"6199_CR137","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M et al (2009) Autophagy regulates lipid metabolism. Nature 458(7242):1131\u20131135. https:\/\/doi.org\/10.1038\/nature07976","journal-title":"Nature"},{"key":"6199_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156846","volume":"143","author":"M Yang","year":"2025","unstructured":"Yang M, Qin W, Dai Q, Wu S, Chen Y, Xie W et al (2025) 18\u03b2-glycyrrhetinic acid mitigates lipotoxicity-induced premature senescence of tubular epithelial cells by activating SIRT1-TFEB signaling. Phytomedicine 143:156846. https:\/\/doi.org\/10.1016\/j.phymed.2025.156846","journal-title":"Phytomedicine"},{"issue":"2","key":"6199_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-024-01156-w","volume":"38","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhao Y, Liu YQ, Fang YP, Sun L, Wei SZ et al (2025) High glucose induces renal tubular epithelial cell senescence by inhibiting autophagic flux. Hum Cell 38(2):43. https:\/\/doi.org\/10.1007\/s13577-024-01156-w","journal-title":"Hum Cell"},{"issue":"11","key":"6199_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04326-y","volume":"12","author":"Y Han","year":"2021","unstructured":"Han Y, Xiong S, Zhao H, Yang S, Yang M, Zhu X et al (2021) Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy. Cell Death Dis 12(11):1031. https:\/\/doi.org\/10.1038\/s41419-021-04326-y","journal-title":"Cell Death Dis"},{"issue":"1","key":"6199_CR141","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12882-024-03664-1","volume":"25","author":"S Zac Varghese","year":"2024","unstructured":"Zac Varghese S, Mark P, Bain S, Banerjee D, Chowdhury TA, Dasgupta I et al (2024) Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024. MC Nephrol 25(1):216. https:\/\/doi.org\/10.1186\/s12882-024-03664-1","journal-title":"MC Nephrol"},{"key":"6199_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104286","volume":"146","author":"Y Zuo","year":"2019","unstructured":"Zuo Y, Li T, Lei Z (2019) Should we add atorvastatin to irbesartan for improving renoprotective effects in early diabetic nephropathy? A meta-analysis of randomized controlled trials. Pharmacol Res 146:104286. https:\/\/doi.org\/10.1016\/j.phrs.2019.104286","journal-title":"Pharmacol Res"},{"issue":"1","key":"6199_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01587-x","volume":"17","author":"SI Alraddadi","year":"2025","unstructured":"Alraddadi SI, Almodaimegh H, Kharbosh A, Alharbi H, Fathelrahman AI, Alsheikh MY, Alfehaid L (2025) Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis. Diabetol Metab Syndr 17(1):41. https:\/\/doi.org\/10.1186\/s13098-025-01587-x","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"6199_CR144","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jacc.2025.04.049","volume":"86","author":"PR Taub","year":"2025","unstructured":"Taub PR, Gutierrez A, Wewers D, Garcia Cantu E, Cao H, Deck C et al (2025) Safety and lipid-lowering lfficacy of inclisiran monotherapy in patients without ASCVD: The VICTORION-Mono randomized clinical trial. J Am Coll Cardiol 86(3):196\u2013208. https:\/\/doi.org\/10.1016\/j.jacc.2025.04.049","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6199_CR145","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1305","volume":"14","author":"MA Afzal","year":"2024","unstructured":"Afzal MA, Khalid N, Abdullah M, Haiy AU, Hassan MA, Sana H et al (2024) The latest evidence on bempedoic acid: meta-analysis of safety and efficacy in high cardiovascular risk patients with hypercholesterolemia. J Community Hosp Intern Med Perspect 14(2):12. https:\/\/doi.org\/10.55729\/2000-9666.1305","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"2","key":"6199_CR146","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jcjd.2021.07.004","volume":"46","author":"M Mohsen","year":"2022","unstructured":"Mohsen M, Elberry AA, Rabea AM, Khalil DM, Abdelrahim M, Hussein R (2022) A new clinical utility for tubular markers to identify kidney responders to saxagliptin treatment in adults with diabetic nephropathy. Can J Diabetes 46(2):134-141.e2. https:\/\/doi.org\/10.1016\/j.jcjd.2021.07.004","journal-title":"Can J Diabetes"},{"key":"6199_CR147","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7382620","volume":"2021","author":"T Trakarnvanich","year":"2021","unstructured":"Trakarnvanich T, Satirapoj B, Suraamornkul S, Chirananthavat T, Sanpatchayapong A, Claimon T (2021) Effect of dipeptidyl peptidase-4 (DPP-4) inhibition on biomarkers of kidney injury and vascular calcification in diabetic kidney disease: a randomized controlled trial. J Diabetes Res 2021:7382620. https:\/\/doi.org\/10.1155\/2021\/7382620","journal-title":"J Diabetes Res"},{"issue":"4","key":"6199_CR148","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10157-020-02007-2","volume":"25","author":"S Yamada","year":"2021","unstructured":"Yamada S, Tanabe J, Ogura Y, Nagai Y, Sugaya T, Ohata K et al (2021) Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats. Clin Exp Nephrol 25(4):365\u2013375. https:\/\/doi.org\/10.1007\/s10157-020-02007-2","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"6199_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70628","volume":"29","author":"J Liu","year":"2025","unstructured":"Liu J, Liu B, Fan E, Zhang H, Yin Z, Lv S et al (2025) Qianshi mixture treats diabetic nephropathy by regulating lipid metabolism reprogramming and inhibiting oxidative stress damage. J Cell Mol Med 29(10):e70628. https:\/\/doi.org\/10.1111\/jcmm.70628","journal-title":"J Cell Mol Med"},{"issue":"10","key":"6199_CR150","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00592-025-02492-5","volume":"62","author":"J Tao","year":"2025","unstructured":"Tao J, Zhang XY, Tan HB, Huang MY, Yang YQ, Guo J (2025) FTZ alleviates lipid deposition in diabetic kidney disease by AMPK\/ACC\/SREBP signaling pathway. Acta Diabetol 62(10):1621\u20131630. https:\/\/doi.org\/10.1007\/s00592-025-02492-5","journal-title":"Acta Diabetol"},{"issue":"2","key":"6199_CR151","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13105-022-00874-9","volume":"78","author":"S Liu","year":"2022","unstructured":"Liu S, Da J, Yu J, Dong R, Yuan J, Yu F, Zha Y (2022) Renal tubule ectopic lipid deposition in diabetic kidney disease rat model and in vitro mechanism of leptin intervention. J Physiol Biochem 78(2):389\u2013399. https:\/\/doi.org\/10.1007\/s13105-022-00874-9","journal-title":"J Physiol Biochem"},{"issue":"12","key":"6199_CR152","first-page":"13776","volume":"13","author":"Q Liao","year":"2021","unstructured":"Liao Q, Xu W, Luo Q, Wen X (2021) Zhenqing recipe relieves diabetic nephropathy through the SIK1\/SREBP-1c axis in type 2 diabetic rats. Am J Transl Res 13(12):13776\u201313783","journal-title":"Am J Transl Res"},{"issue":"1","key":"6199_CR153","first-page":"65","volume":"37","author":"L Ma","year":"2024","unstructured":"Ma L, Zhang X, Li Y, Bai D (2024) Leonuride protects diabetic nephropathy by activating SREBPs pathway. Pak J Pharm Sci 37(1):65\u201370","journal-title":"Pak J Pharm Sci"},{"issue":"4","key":"6199_CR154","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000541690","volume":"149","author":"M Luo","year":"2025","unstructured":"Luo M, Hu Z, Yang J, Yang J, Sheng W, Lin C et al (2025) Diosgenin improves lipid metabolism in diabetic nephropathy via regulation of miR-148b-3p\/DNMT1\/FOXO1 axis. Nephron 149(4):226\u2013239. https:\/\/doi.org\/10.1159\/000541690","journal-title":"Nephron"},{"issue":"24","key":"6199_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417380","volume":"24","author":"A Mujalli","year":"2023","unstructured":"Mujalli A, Farrash WF, Obaid AA, Khan AA, Almaimani RA, Idris S et al (2023) Improved glycaemic control and nephroprotective effects of empagliflozin and paricalcitol co-therapy in mice with type 2 diabetes mellitus. Int J Mol Sci 24(24):17380. https:\/\/doi.org\/10.3390\/ijms242417380","journal-title":"Int J Mol Sci"},{"key":"6199_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110711","volume":"385","author":"W Zhu","year":"2023","unstructured":"Zhu W, Chen M, Wang Y, Chen Y, Zhang Y, Wang Y et al (2023) Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB\/TNF-a\/SREBP1c signaling pathway. Chem Biol Interact 385:110711. https:\/\/doi.org\/10.1016\/j.cbi.2023.110711","journal-title":"Chem Biol Interact"},{"key":"6199_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2025.106474","volume":"182","author":"W Qu","year":"2025","unstructured":"Qu W, Lan Y, Cheng Z, Yuan H, Zhan H, Lan X et al (2025) Oxybaphus himalaicus alleviates diabetic kidney disease by suppressing the lipid metabolism and inflammation via PPAR\u03b1 signaling. Fitoterapia 182:106474. https:\/\/doi.org\/10.1016\/j.fitote.2025.106474","journal-title":"Fitoterapia"},{"key":"6199_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155705","volume":"130","author":"X Guo","year":"2024","unstructured":"Guo X, Wen S, Wang J, Zeng X, Yu H, Chen Y et al (2024) Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease. Phytomedicine 130:155705. https:\/\/doi.org\/10.1016\/j.phymed.2024.155705","journal-title":"Phytomedicine"},{"issue":"21","key":"6199_CR159","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1042\/CS20220205","volume":"136","author":"WP Martin","year":"2022","unstructured":"Martin WP, Nair M, Chuah YHD, Malmodin D, Pedersen A, Abrahamsson S et al (2022) Dietary restriction and medical therapy drives PPAR\u03b1-regulated improvements in early diabetic kidney disease in male rats. Clin Sci 136(21):1485\u20131511. https:\/\/doi.org\/10.1042\/CS20220205","journal-title":"Clin Sci"},{"key":"6199_CR160","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.12659\/msm.908927","volume":"24","author":"J Sun","year":"2018","unstructured":"Sun J, Chen X, Liu T, Jiang X, Wu Y, Yang S et al (2018) Berberine protects against palmitate-induced apoptosis in tubular epithelial cells by promoting fatty acid oxidation. Med Sci Monit 24:1484. https:\/\/doi.org\/10.12659\/msm.908927","journal-title":"Med Sci Monit"},{"issue":"1","key":"6199_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95827-5","volume":"11","author":"F Wang","year":"2021","unstructured":"Wang F, Sun H, Zuo B, Shi K, Zhang X, Zhang C, Sun D (2021) Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy. Sci Rep 11(1):16362. https:\/\/doi.org\/10.1038\/s41598-021-95827-5","journal-title":"Sci Rep"},{"key":"6199_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1265230","volume":"14","author":"T Khamis","year":"2023","unstructured":"Khamis T, Abdelkhalek A, Abdellatif H, Dwidar N, Said A, Ahmed R et al (2023) BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways. Front Pharmacol 14:1265230. https:\/\/doi.org\/10.3389\/fphar.2023.1265230","journal-title":"Front Pharmacol"},{"issue":"10","key":"6199_CR163","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/jcph.2465","volume":"64","author":"MK Prasad","year":"2024","unstructured":"Prasad MK, Victor PS, Ganesh GV, Juttada U, Kumpatla S, Viswanathan V, Ramkumar KM (2024) Sodium-glucose cotransporter-2 inhibitor suppresses endoplasmic reticulum stress and oxidative stress in diabetic nephropathy through Nrf2 signaling: a clinical and experimental study. J Clin Pharmacol 64(10):1193\u20131203. https:\/\/doi.org\/10.1002\/jcph.2465","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"6199_CR164","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/08923973.2024.2402347","volume":"46","author":"SA El Marasy","year":"2024","unstructured":"El Marasy SA, Farouk H, Khattab MS, Moustafa PE (2024) Beta-carotene ameliorates diabetic nephropathy in rats: involvement of AMPK\/SIRT1\/autophagy pathway. Immunopharmacol Immunotoxicol 46(6):763\u2013772. https:\/\/doi.org\/10.1080\/08923973.2024.2402347","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"16","key":"6199_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163554","volume":"15","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Jin R, Luo R, Liu J, Ren L, Zhang Y et al (2023) Diosgenin targets CaMKK2 to alleviate type II diabetic nephropathy through improving autophagy, mitophagy and mitochondrial dynamics. Nutrients 15(16):3554. https:\/\/doi.org\/10.3390\/nu15163554","journal-title":"Nutrients"},{"key":"6199_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115121","volume":"162","author":"C Xia","year":"2025","unstructured":"Xia C, Zhang J, Chen H, Jiang W, Zhou S, Zheng H, Sun W (2025) Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease. Int Immunopharmacol 162:115121. https:\/\/doi.org\/10.1016\/j.intimp.2025.115121","journal-title":"Int Immunopharmacol"},{"key":"6199_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111948","volume":"142","author":"SM Ezzat","year":"2021","unstructured":"Ezzat SM, Abdallah H, Yassen NN, Radwan RA, Mostafa ES, Salama MM, Salem MA (2021) Phenolics from physalis peruviana fruits ameliorate streptozotocin-induced diabetes and diabetic nephropathy in rats via induction of autophagy and apoptosis regression. Biomed Pharmacother 142:111948. https:\/\/doi.org\/10.1016\/j.biopha.2021.111948","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"6199_CR168","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/cbin.11899","volume":"46","author":"J Siddhi","year":"2022","unstructured":"Siddhi J, Sherkhane B, Kalavala AK, Arruri V, Velayutham R, Kumar A (2022) Melatonin prevents diabetes-induced nephropathy by modulating the AMPK\/SIRT1 axis: focus on autophagy and mitochondrial dysfunction. Cell Biol Int 46(12):2142\u20132157. https:\/\/doi.org\/10.1002\/cbin.11899","journal-title":"Cell Biol Int"},{"key":"6199_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1505637","volume":"16","author":"R Zhang","year":"2025","unstructured":"Zhang R, Lan X, Zhu W, Wang L, Liu P, Li P (2025) Regulation of autophagy by the PI3K-AKT pathway in Astragalus membranaceus -Cornus officinalis to ameliorate diabetic nephropathy. Front Pharmacol 16:1505637. https:\/\/doi.org\/10.3389\/fphar.2025.1505637","journal-title":"Front Pharmacol"},{"key":"6199_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00732","volume":"11","author":"D Wen","year":"2020","unstructured":"Wen D, Tan RZ, Zhao CY, Li JC, Zhong X, Diao H et al (2020) Astragalus mongholicus bunge and panax notoginseng (Burkill) F.H. chen formula for renal injury in diabetic nephropathy\u2014in vivo and in vitro evidence for autophagy regulation. Front Pharmacol 11:732. https:\/\/doi.org\/10.3389\/fphar.2020.00732","journal-title":"Front Pharmacol"},{"key":"6199_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1543277","volume":"16","author":"Z Yan","year":"2025","unstructured":"Yan Z, Zhang L, Ma T, Yuan Y, Kang Y, Liu S et al (2025) Suoquanyishen formula improves renal cellular senescence by inhibiting YTHDF1-Rubicon axis to promote autophagy in diabetic kidney disease. Front Pharmacol 16:1543277. https:\/\/doi.org\/10.3389\/fphar.2025.1543277","journal-title":"Front Pharmacol"},{"issue":"11","key":"6199_CR172","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/dom.14503","volume":"23","author":"MN Kim","year":"2021","unstructured":"Kim MN, Moon JH, Cho YM (2021) Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation. Diabetes Obes Metab 23(11):2561\u20132571. https:\/\/doi.org\/10.1111\/dom.14503","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6199_CR173","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1038\/s41467-022-32477-9","volume":"13","author":"MdM Al Dabet","year":"2022","unstructured":"Al Dabet MdM, Shahzad K, Elwakiel A, Sulaj A, Kopf S, Bock F et al (2022) Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression. Nat Commun 13(1):5062. https:\/\/doi.org\/10.1038\/s41467-022-32477-9","journal-title":"Nat Commun"},{"key":"6199_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.926211","volume":"13","author":"D Liang","year":"2022","unstructured":"Liang D, Li Z, Feng Z, Yuan Z, Dai Y, Wu X et al (2022) Metformin improves the senescence of renal tubular epithelial cells in a high-glucose state through E2F1. Front Pharmacol 13:926211. https:\/\/doi.org\/10.3389\/fphar.2022.926211","journal-title":"Front Pharmacol"},{"key":"6199_CR175","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson LJ, Langhi PL, Bobart SA, Evans TK, Giorgadze N, Hashmi SK et al (2019) Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47:446\u2013456. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069","journal-title":"EBioMedicine"},{"key":"6199_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8507","author":"XM Ji","year":"2025","unstructured":"Ji XM, Dong XX, Li JP, Tai GJ, Qiu S, Wei W et al (2025) Fisetin clears senescent cells through the Pi3k-Akt-Bcl-2\/Bcl-xl pathway to alleviate diabetic aortic aging. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.8507","journal-title":"Phytother Res"},{"key":"6199_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176699","volume":"976","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Qu Y, Cai R, Gao J, Xu Q, Zhang L et al (2024) Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling. Eur J Pharmacol 976:176699. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176699","journal-title":"Eur J Pharmacol"},{"key":"6199_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.819787","volume":"13","author":"J Xiang","year":"2022","unstructured":"Xiang J, Zhang H, Zhou X, Wang D, Chen R, Tan W et al (2022) Atorvastatin pestores PPAR\u03b1 inhibition of lipid metabolism disorders by downregulating miR-21 expression to improve mitochondrial function and alleviate diabetic nephropathy progression. Front Pharmacol 13:819787. https:\/\/doi.org\/10.3389\/fphar.2022.819787","journal-title":"Front Pharmacol"},{"issue":"1","key":"6199_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35944-z","volume":"14","author":"TS Huang","year":"2023","unstructured":"Huang TS, Wu T, Wu YD, Li XH, Tan J, Shen CH et al (2023) Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice. Nat Commun 14(1):390. https:\/\/doi.org\/10.1038\/s41467-023-35944-z","journal-title":"Nat Commun"},{"key":"6199_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1381746","volume":"15","author":"J Guo","year":"2024","unstructured":"Guo J, Jiang Z, Xia Y, Wang H, Tang Q, Meng B (2024) The association between statin use and diabetic nephropathy in US adults: data from NHANES 2005 - 2018. Front Endocrinol 15:1381746. https:\/\/doi.org\/10.3389\/fendo.2024.1381746","journal-title":"Front Endocrinol"},{"issue":"1","key":"6199_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04432-5","volume":"26","author":"K Xie","year":"2025","unstructured":"Xie K, Ma Y, Din J, Jin Y, Zhang S, Liu S et al (2025) Research and advances in mouse models of diabetic nephropathy: a narrative review. BMC Nephrol 26(1):511. https:\/\/doi.org\/10.1186\/s12882-025-04432-5","journal-title":"BMC Nephrol"},{"issue":"11","key":"6199_CR182","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1007\/s11255-025-04562-7","volume":"57","author":"H Bin","year":"2025","unstructured":"Bin H, Wen W (2025) Metformin attenuates endoplasmic reticulum stress in diabetic kidney disease: mechanistic insights and future perspectives. Int Urol Nephrol 57(11):3701\u20133707. https:\/\/doi.org\/10.1007\/s11255-025-04562-7","journal-title":"Int Urol Nephrol"},{"issue":"20","key":"6199_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207676","volume":"21","author":"K Shirakawa","year":"2020","unstructured":"Shirakawa K, Sano M (2020) Sodium-glucose co-transporter 2 inhibitors correct metabolic maladaptation of proximal tubular epithelial cells in high-glucose conditions. Int J Mol Sci 21(20):7676. https:\/\/doi.org\/10.3390\/ijms21207676","journal-title":"Int J Mol Sci"},{"key":"6199_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1142276","volume":"14","author":"T Liu","year":"2023","unstructured":"Liu T, Jin Q, Yang L, Mao H, Ma F, Wang Y et al (2023) Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism. Front Endocrinol 14:1142276. https:\/\/doi.org\/10.3389\/fendo.2023.1142276","journal-title":"Front Endocrinol"},{"key":"6199_CR185","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2024.12.005","volume":"277","author":"SY Chang","year":"2025","unstructured":"Chang SY, Liao MC, Miyata KN, Pang Y, Zhao XP, Peng J et al (2025) Canagliflozin inhibits hedgehog interacting protein (Hhip) induction of tubulopathy in diabetic akita mice. Transl Res 277:13\u201326. https:\/\/doi.org\/10.1016\/j.trsl.2024.12.005","journal-title":"Transl Res"},{"key":"6199_CR186","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2024.12.005","volume":"277","author":"T Eleftheriadis","year":"2022","unstructured":"Eleftheriadis T, Pissas G, Filippidis G, Efthymiadi M, Liakopoulos V, Stefanidis I (2022) Dapagliflozin prevents high-glucose-induced cellular senescence in renal tubular epithelial cells. Int J Mol Sci 277:13\u201326. https:\/\/doi.org\/10.1016\/j.trsl.2024.12.005","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6199_CR187","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1039\/c8fo01653d","volume":"10","author":"C Ge","year":"2019","unstructured":"Ge C, Xu M, Qin Y, Gu T, Lou D, Li Q et al (2019) <article-title update=\"added\">Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation. Food Funct 10(5):2970\u20132985. https:\/\/doi.org\/10.1039\/c8fo01653d","journal-title":"Food Funct"},{"issue":"24","key":"6199_CR188","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"issue":"15","key":"6199_CR189","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"issue":"2","key":"6199_CR190","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"E-KCG The","year":"2023","unstructured":"The E-KCG, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ et al (2023) Empagliflozin in patients with chronic kidney disease. N Engl J Med 388(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N Engl J Med"},{"issue":"2","key":"6199_CR191","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G et al (2024) Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med 391(2):109\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa2403347","journal-title":"N Engl J Med"},{"issue":"1","key":"6199_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01476-x","volume":"21","author":"AD Kaze","year":"2022","unstructured":"Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM (2022) Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol 21(1):47. https:\/\/doi.org\/10.1186\/s12933-022-01476-x","journal-title":"Cardiovasc Diabetol"},{"key":"6199_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01171-3","author":"V Martinez Leon","year":"2025","unstructured":"Martinez Leon V, Hilburg R, Susztak K (2025) Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/s41574-025-01171-3","journal-title":"Nat Rev Endocrinol"},{"issue":"23","key":"6199_CR194","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P et al (2020) Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383(23):2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"issue":"11","key":"6199_CR195","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4239\/wjd.v11.i11.553","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Xue S, Hou J, Chen G, Xu ZG (2020) Endothelin receptor antagonists for the treatment of diabetic nephropathy: a meta-analysis and systematic review. World J Diabetes 11(11):553\u2013566. https:\/\/doi.org\/10.4239\/wjd.v11.i11.553","journal-title":"World J Diabetes"},{"issue":"5S","key":"6199_CR196","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"Kidney Disease: Improving Global Outcomes Diabetes Work G","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes Diabetes Work G (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102(5S):S1\u2013S127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008","journal-title":"Kidney Int"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06199-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06199-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06199-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:54:50Z","timestamp":1781218490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06199-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":196,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6199"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06199-w","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"252"}}